跳至主要内容
临床试验/IRCT20200506047323N1
IRCT20200506047323N1已完成3 期

The effects of Ginger on clinical manifestations and paraclinical features of patients with COVID-19: A randomized double-blind placebo-control clinical trial

Bandare-abbas University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age =18 years
  • Positive polymerase chain reaction (PCR) test for COVID-19 or/and lung involvement in imaging
  • Primary clinical symptoms
  • Hospitalized
  • Signing informed consent and willingness of study participant to accept randomization to any assigned treatment arm

排除标准

  • Underlying diseases, including chronic hepatitis, cirrhosis, cholestatic liver diseases, cholecystitis, and peptic ulcers
  • Use of anticoagulant drugs like warfarin, and hormonal drugs
  • History of allergy to ginger
  • Pregnancy and breastfeeding

研究者

发起方
Bandare-abbas University of Medical Sciences

相似试验